The growth hormone receptor exon 3 polymorphism is not associated with height or metabolic traits in healthy young adults (2014)
- Authors:
- USP affiliated authors: CASTRO, MARGARET DE - FMRP ; BARBIERI, MARCO ANTONIO - FMRP ; BETTIOL, HELOISA - FMRP ; JORGE, ALEXANDER AUGUSTO DE LIMA - FM ; ANTONINI, SONIR ROBERTO RAUBER - FMRP
- Unidades: FMRP; FM
- DOI: 10.1016/j.ghir.2014.04.005
- Subjects: HORMÔNIO DO CRESCIMENTO; NASCIMENTO (FATORES HUMANOS); DOENÇAS CARDIOVASCULARES
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Growth Hormone and IGF Research
- ISSN: 1096-6374
- Volume/Número/Paginação/Ano: v. 24, n. 4, p. 123-129, 2014
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
MARTINS, Clarissa S. et al. The growth hormone receptor exon 3 polymorphism is not associated with height or metabolic traits in healthy young adults. Growth Hormone and IGF Research, v. 24, n. 4, p. 123-129, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.ghir.2014.04.005. Acesso em: 24 abr. 2024. -
APA
Martins, C. S., Rosa, F. L. F., Espineira, A. R., Souza, R. M. de, Castro, M. de, Barbieri, M. A., et al. (2014). The growth hormone receptor exon 3 polymorphism is not associated with height or metabolic traits in healthy young adults. Growth Hormone and IGF Research, 24( 4), 123-129. doi:10.1016/j.ghir.2014.04.005 -
NLM
Martins CS, Rosa FLF, Espineira AR, Souza RM de, Castro M de, Barbieri MA, Bettiol H, Jorge AA de L, Antonini SRR. The growth hormone receptor exon 3 polymorphism is not associated with height or metabolic traits in healthy young adults [Internet]. Growth Hormone and IGF Research. 2014 ; 24( 4): 123-129.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.ghir.2014.04.005 -
Vancouver
Martins CS, Rosa FLF, Espineira AR, Souza RM de, Castro M de, Barbieri MA, Bettiol H, Jorge AA de L, Antonini SRR. The growth hormone receptor exon 3 polymorphism is not associated with height or metabolic traits in healthy young adults [Internet]. Growth Hormone and IGF Research. 2014 ; 24( 4): 123-129.[citado 2024 abr. 24 ] Available from: https://doi.org/10.1016/j.ghir.2014.04.005 - The consequences of catch-up growth in infancy on cardiometabolic profile and adiponectinemia persist in young healthy adults born small for gestational age
- Postnatal growth and cardiometabolic profile in young adults born large for gestational age
- The insulin gene VNTR(INS VNTR) is associated with cardiovascular risk markers in young adults born large for gestational age(LGA)
- Adiponectin: serum levels, promoter polymorphism, and associations with birth size and cardiometabolic outcome in young adults born large for gestational age
- Inhibition of the Tcf/beta-catenin complex increases apoptosis and impairs adrenocortical tumor cell proliferation and adrenal steroidogenesis
- Mineralocorticoid receptor p.I180V polymorphism: association with body mass index and LDL-cholesterol levels
- miR-449 does not regulate Wnt pathway genes in adrenocortical tumor cell line
- Letter to the Editor. [Carta]: comments on "LGR5 activates noncanonical Wnt signaling and inhibits aldosterone production in the human adrenal" by Shaikh L. H., et al
- A novel ADIPOQ mutation (p.M40K) results in impaired high-molecular-weight adiponectin and associates with obesity and early-onset metabolic syndrome
- A Novel ADIPOQ mutation (p.M40K) impairs assembly of high-molecular-weight adiponectin and is associated with early-onset obesity and metabolic syndrome
Informações sobre o DOI: 10.1016/j.ghir.2014.04.005 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
